Skip to Content
Webinar Recording

A Combination Treatment for Patients with Advanced Renal Cell Carcinoma

Recorded on: March 5, 2025

 

How can clinicians maximize the efficacy of cabozantinib in combination therapy for advanced renal cell carcinoma while minimizing toxicity?

Jennifer Hasiak, PharmD, breaks down the latest data on cabozantinib combinations, discusses strategies to mitigate adverse effects, and highlights key resources to support both clinicians and patients.